Cytokinetics

CYTK · NASDAQ

$63.95+$1.30 (+2.08%)TodayMarket closed ·
Prev close $62.65

Who owns CYTK

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 57.3% of CYTK’s shares.

  • T. Rowe Price Investment Management, Inc.13.8%
  • BlackRock Institutional Trust Company, N.A.12.0%
  • Wellington Management Company, LLP5.1%
  • Vanguard Portfolio Management, LLC5.0%
  • Next 6 largest institutions21.5%
  • All other shareholders42.7%
Top institutional holders of CYTK
HolderShares% of shares
T. Rowe Price Investment Management, Inc.18.72M13.81%
BlackRock Institutional Trust Company, N.A.16.24M11.98%
Wellington Management Company, LLP6.93M5.11%
Vanguard Portfolio Management, LLC6.71M4.95%
State Street Investment Management (US)6.49M4.79%
Vanguard Capital Management, LLC6.12M4.51%
Avoro Capital Advisors LLC5.00M3.69%
Fidelity Management & Research Company LLC4.81M3.54%
Geode Capital Management, L.L.C.3.71M2.74%
Bank of America Private Bank2.95M2.18%

Largest mutual fund holders

Top mutual fund holders of CYTK
HolderShares% of shares
T. Rowe Price Capital Appreciation Fund6.29M4.64%
iShares Core S&P Mid-Cap ETF4.75M3.51%
Vanguard Total Stock Market Index Fund4.33M3.19%
iShares Russell 2000 ETF3.40M2.51%
Vanguard Small-Cap Index Fund3.12M2.30%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $28.18M (41 trades) of CYTK on the open market, with no buys.

Latest CYTK insider transactions
InsiderTypeSharesValue
Blum Robert IOption exercise7.50K—
Blum Robert ISale7.50K$471.60K
Blum Robert IOption exercise7.50K$79.50K
Malik Fady IbrahamOption exercise3.50K—
Malik Fady IbrahamSale3.50K$214.83K
Malik Fady IbrahamOption exercise3.50K$27.30K
Blum Robert IOption exercise7.50K—
Blum Robert ISale7.50K$490.95K
Blum Robert IOption exercise7.50K$79.50K
Malik Fady IbrahamOption exercise3.50K—

Short interest

Settled Sep 30, 2026

Shares short
19.33M
Days to cover
8.37
% of shares outstanding
14.26%
Average daily volume
2.31M
Change since last report
+10.6%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.